RT Journal Article
T1 Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic.
A1 Moreno, Raúl
A1 Díez, José-Luis
A1 Diarte, José-Antonio
A1 Salinas, Pablo
A1 de la Torre Hernández, José María
A1 Andres-Cordón, Juan F
A1 Trillo, Ramiro
A1 Briales, Juan Alonso
A1 Amat-Santos, Ignacio
A1 Romaguera, Rafael
A1 Díaz, José-Francisco
A1 Vaquerizo, Beatriz
A1 Ojeda, Soledad
A1 Cruz-González, Ignacio
A1 Morena-Salas, Daniel
A1 Pérez de Prado, Armando
A1 Sarnago, Fernando
A1 Portero, Pilar
A1 Gutierrez-Barrios, Alejandro
A1 Alfonso, Fernando
A1 Bosch, Eduard
A1 Pinar, Eduardo
A1 Ruiz-Arroyo, José-Ramón
A1 Ruiz-Quevedo, Valeriano
A1 Jiménez-Mazuecos, Jesús
A1 Lozano, Fernando
A1 Rumoroso, José-Ramón
A1 Novo, Enrique
A1 Irazusta, Francisco J
A1 García Del Blanco, Bruno
A1 Moreu, José
A1 Ballesteros-Pradas, Sara M
A1 Frutos, Araceli
A1 Villa, Manuel
A1 Alegría-Barrero, Eduardo
A1 Lázaro, Rosa
A1 Paredes, Emilio
K1 COVID-19
K1 Diabetes
K1 Interventional cardiology
K1 Mortality
K1 Waiting list
AB During COVID-19 pandemic, elective invasive cardiac procedures (ICP) have been frequently cancelled or postponed. Consequences may be more evident in patients with diabetes. The objective was to identify the peculiarities of patients with DM among those in whom ICP were cancelled or postponed due to the COVID-19 pandemic, as well as to identify subgroups in which the influence of DM has higher impact on the clinical outcome. We included 2,158 patients in whom an elective ICP was cancelled or postponed during COVID-19 pandemic in 37 hospitals in Spain. Among them, 700 (32.4%) were diabetics. Patients with and without diabetes were compared. Patients with diabetes were older and had a higher prevalence of other cardiovascular risk factors, previous cardiovascular history and co-morbidities. Diabetics had a higher mortality (3.0% vs. 1.0%; p = 0.001) and cardiovascular mortality (1.9% vs. 0.4%; p = 0.001). Differences were especially important in patients with valvular heart disease (mortality 6.9% vs 1.7% [p  Among patients in whom an elective invasive cardiac procedure is cancelled or postponed during COVID-19 pandemic, mortality and cardiovascular mortality is higher in patients with diabetes, irrespectively on other clinical conditions. These procedures should not be cancelled in patients with diabetes.
YR 2021
FD 2021-03-23
LK http://hdl.handle.net/10668/17392
UL http://hdl.handle.net/10668/17392
LA en
DS RISalud
RD Apr 10, 2025